94 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
86
SCIENTIFIC PROGRAMME
ME-01
Meet-the-Expert
10:00– 11:00
|
Hall A2
TOPIC 23:
Health care research and models, health care
policy
Global mental health: the fundamental questions
Chairs:
Berend Malchow, Germany
Madalina Hostiuc, Germany
Speaker:
Graham Thornicroft, United Kingdom
ST-02 (d)
State-of-the-Art-Symposium
10:00– 11:30
|
Hall A6 /A7
TOPIC 5:
Neurotic, stress-related and somatoform
disorders
Zwangsstörungen
Chairs:
Fritz Hohagen, Germany
Ulrich Voderholzer, Germany
001
Psychotherapie der Zwangsstörungen
Fritz Hohagen, Germany
002
State-of-the-Art der Pharmakotherapie bei
Zwangsstörungen und neue therapeutische Entwick-
lungen
Ulrich Voderholzer, Germany
ST-03 (d)
State-of-the-Art-Symposium
10:00– 11:30
|
Hall A3
TOPIC 5:
Neurotic, stress-related and somatoform
disorders
Dissoziative Störungen
Chairs:
Carsten Spitzer, Germany
Kathlen Priebe, Germany
S-022
Symposium
10:00– 11:30
|
Hall A5
TOPIC 18:
Pharmacotherapy
Antidepressants – proof of evidence vs. critical
reception in public
Chairs:
Siegfried Kasper, Austria
Hans-Jürgen Möller, Germany
001
Efficacy of antidepressiva is well
Elias Erikson, Sweden
002
The antidepressiva-criticism in the mass-media
Kostas Fountoulakis, Greece
003
Ways to improve the efficacy of antidepressiva
in non-responsive patients?
Siegfried Kasper, Austria
004
AD or/and psychotherapy: the clinical perspective
Gerd Laux, Germany
S-023
Symposium
10:00– 11:30
|
Hall A1
TOPIC 8:
Disorders closely related to childhood and
adolescence
Clinical staging in psychiatry – next steps for early
intervention and personalized treatment
Chairs:
Wim Veling, The Netherlands
Patrick McGorry, Australia
001
Prevalence and sociodemographic correlates
of emotional disorder in an inner-city cohort: the
Resilience, Ethnicity, and AdolesCent Mental Health
(REACH) study
Craig Morgan, United Kingdom
002
Psychotic experiences as marker of developing
psychopathology in adolescence: the MasterMind
study
Saliha El-Bouhaddani, The Netherlands
Lieke van Domburgh, Barbara Schaefer,
Theo Doreleijers, Wim Veling
003
Symptoms and functioning after first episode
of psychosis – clinical staging in the Psychosis
Recent Onset GRoningen Survey (PROGR-S)
Wim Veling, The Netherlands
Vera Brink, Catheleine van Driel, Edith Liemburg, Stynke
Castelein
004
The next stage of early intervention: transdiag-
nostic, personalized, universal
Patrick McGorry, Australia
S-024
Symposium
10:00– 11:30
|
Hall A4
TOPIC 14:
Neurobiology and genetics
Discovery of genetic signatures of mental diseases:
approaches from top-down and from bottom-up
Chairs:
Michael O'Donovan, United Kingdom
Hannelore Ehrenreich, Germany
001
PGC GWAS schizophrenia – history, state and
future perspectives
Michael O'Donovan, United Kingdom
002
Educational attainment GWAS as tool to
approach biological subgroups of mental disease
Philipp Koellinger, The Netherlands
003
Common psychiatric disorders share the same
genetic origin – consequences for adverse outcomes
Paul Lichtenstein, Sweden
004
OTTO: a new strategy to extract mental
disease-relevant combinations of GWAS hits from
individuals
Hannelore Ehrenreich, Germany